Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep361 | Clinical case reports - Thyroid/Others | ECE2016

131I uptake in nonlactating breast related to papillary thyroid carcinoma

Yeboles Josu Perez , Larranaga Unanue Ihintza , Etxebeste Ioana Cillero

Introduction: Radioiodine whole-body scintigraphy (WBS) has been widely used for detection of differentiated thyroid cancer (DTC), based on the marked storage of iodine in functioning thyroid tissue. However, radioiodine uptake is not specific for thyroid gland. Iodine accumulation in lactating breast has been demonstrated, but it is rare in nonlactating breast.Case report: A 74-year-old-woman who underwent near-total thyroidectomy in 1988 due to a multi...

ea0026p478 | Thyroid cancer | ECE2011

Incidentally discovered thyroid carcinomas. An experience of a centre through 18 years

Lizarraga Aitzol , Paja Miguel , Sanchez Maider , Barrios Borja , Perez Josu , Arosa Vanessa

Incidental thyroid carcinoma includes thyroid carcinomas detected after surgery in patients whose thyroid has been correctly studied with no data of malignancy. Lately, the widely spread use of image techniques and thorough search of thyroid nodule complains, have lead to a growing number of thyroid carcinomas. But still there are some of these incidentally discovered after thyroidectomy.We report 98 cases of thyroid carcinomas incidentally found from a ...

ea0022p240 | Clinical case reports and clinical practice | ECE2010

Synergic effect of Cabergoline in acromegaly treated with somatostatin analogues. Report of two cases

Paja Miguel , Perez-Yeboles Josu , Lizarraga Aitzol , Moreno Cristina , Isusquiza Ana , Elorza J Ramon

Current treatment for acromegaly includes dopamine agonists (DA), somatostatin receptor ligands (SRL) and GH receptor antagonists (GHRA). DA in monotherapy, is less than 10% effective achieving control of the disease, and its efficacy in addition to ongoing SRL is less studied, without obvious determining factors of response. We report 2 operated patients with incomplete response to SRL and to whom Cabergoline addition led to disease control.Case 1: A ma...

ea0022p838 | Thyroid | ECE2010

Simultaneous thyroid and gastric autoimmune disease: clinical aspects of 78 cases

Paja Miguel , Lizarraga Aitzol , Moreno Cristina , Ugarte Estibaliz , Perez-Yeboles Josu , Oleaga Amelia

Autoimmune polyendocrinopathy syndromes (APS) gather a wide range of diseases. The association of autoimmune thyroid disease (ATD) with other organ specific diseases is frequent. Atrophic body gastritis (ABP) is characterized by the loss of ClH and intrinsic factor (IF) production. Both ATD and ABP are known to be associated since 1960 but there are scarce publications describing its clinical features.We review patients with this association selected fro...

ea0016p808 | Thyroid | ECE2008

Is pre-ablative thyroglobulin useful as a predictor of cure in differentiated thyroid carcinoma?

Paja Miguel , Oleaga Amelia , Perez Josu , Lizarraga Aitzol , Moreno Cristina , Izuzquiza Ana , Goni Fernando

Surgery followed by 131I ablative therapy (IAT) is the usual treatment for patients with differentiated thyroid carcinoma (DTC). Thyroglobulin levels obtained 9–12 months after IAT under TSH stimulation (Tg2) is a very reliable marker for the presence of thyroid tissue. The value of stimulated thyroglobulin previous to ablation (Tg1) is more controversial. The aim of this study was to examine the relationship between Tg1 and Tg2.Material ...

ea0081ep366 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Characterization of a cohort of patients with type 1 diabetes during their unstructured transition to adult care

Braca Fernando , Novoa Yeray , Betancor Acosta Juan Carmelo , Fernandez-Trujillo Paula , Alvarado Martel Dacil , Gonzalez Martin Josu , Maria Wagner Ana

Background and aims: Transition of patients with type 1 diabetes (DM1) from pediatric to adult care is challenging and international guidelines recommend effective transition programs. The aim of this study is to describe our baseline situation, without a structured transition program, and to identify factors associated with worse glycemic outcome.Materials and Methods: This is an observational, retrospective study of patients with DM1, aged 14 or more o...

ea0020p103 | Thyroid | ECE2009

The role of large-neddle biopsy (LNB) in thyroid nodules: validation with surgical results in more than 100 cases

Paja Miguel , Perez-Yeboles Josu , Sanchez Maider , Izuzquiza Ana , Ugarte Estibaliz , Zabala Rosa , Lopez Jose I , Oleaga Amelia

Fine-needle aspiration cytology (FNAC) remains the mainstay in the study of thyroid nodules, with cytologic adequate specimens in almost 85% of cases in expert hands. Apart from the limitation of inadequate samples, there are false negative diagnoses in some cases, particularly in larger (>3 cm) nodules. Considering this, Large-needle biopsy (LNB) could be useful to improve diagnostic precision. We review the pathology reports (PR) of more than 100 patients operated since ...

ea0073ep31 | Calcium and Bone | ECE2021

Recurrent and persistent primary hyperparathyroidism due to secondary parathyromatosis

Everardo Josué Díaz-López , Alejandro Ramírez-Izcoa , José Vinicio Velecela Abambari , Adalberto Infante-Amorós

IntroductionParathyromatosis is a potential cause of recurrent hyperparathyroidism, of rare etiology, described as multiple nodules of hyperfunctioning benign parathyroid tissue, it constitutes less than 1% of the cases of recurrent hyperparathyroidism and since its description in 1975, less than 40 cases have been reported Worldwide. The presentation in primary hyperparathyroidism is extremely rare, with around 20 cases reported in the English literatur...

ea0073aep186 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Cardiorenal outcomes and T2DM control in new users of SGLT2 inhibitors in combination therapy

Ihintza Larrañaga , Vives Cristina Goena , Maria Magdalena Arteaga Ossa , Jose Francisco Egido Arroyo , Begoña Maíz Alcorta , Laura Mañas Alonso , Ovejero Laura Quintas , Rodrigo Ana Moreno , Nerea Andrés Imaz , Amaia Cristina Armentia Del Pozo , Abasolo Amaia Aspiazu , Villar Ruth Agirrezabalaga , Irene Larrañaga Gomez , Irizar Sara Diez , Suarez Teresa Arana , Dadebat Naroa Rico , Josu Pérez Yéboles

Introduction and objectivesSGT2i have changed the paradigm of T2DM management. Last guidelines insist on the importance of using newer glucose-lowering drugs with a demonstrated reduction in cardiovascular events (CVE). The aim of this study is twofold: to describe CVE, heart failure (HF) and renal function evolution; and to assess its efficacy in non-selected patients with T2DM initiating SGLT2iMaterial and methods<p class="ab...